David Zeferino D'Azevedo Cristina
Algemeen Directeur bij Acellera Therapeutics Lda.
Profiel
David Zeferino D'Azevedo Cristina is the founder and Chief Executive Officer of Acellera Therapeutics Lda.
which was founded in 2010.
He is currently a Director at Lymphact - Lymphocyte Activation Technologies SA. Dr. D'Azevedo Cristina was previously an Investment Consultant at Portugal Capital Ventures SCR SA from 2015 to 2017.
Actieve functies van David Zeferino D'Azevedo Cristina
| Bedrijven | Functie | Begin |
|---|---|---|
Acellera Therapeutics Lda.
 Acellera Therapeutics Lda. BiotechnologyHealth Technology Acellera Therapeutics Lda. engages in the development of platform technology for immunessupression to treat immune-mediated diseases. The company is headquartered in Lisbon, Portugal. | Algemeen Directeur | 01-07-2010 |
Lymphact - Lymphocyte Activation Technologies SA
 Lymphact - Lymphocyte Activation Technologies SA BiotechnologyHealth Technology Lymphact - Lymphocyte Activation Technologies SA provides biotechnology solutions. It develops treatments for cancer and chronic viral diseases. The firm offers a technology platform that generates autologous and heterologous cellular immune therapies for clinical applications. The company was founded by Diogo Remechido in 2013 and is headquartered in Lisbon, Portugal. | Directeur/Bestuurslid | - |
Eerdere bekende functies van David Zeferino D'Azevedo Cristina
| Bedrijven | Functie | Einde |
|---|---|---|
Portugal Capital Ventures SCR SA
 Portugal Capital Ventures SCR SA Investment ManagersFinance Portugal Capital Ventures SCR SA (Portugal Capital) is a venture capital firm founded in 1989. The firm is headquartered in Porto, Portugal. | Consultant / Adviseur | 31-10-2017 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Acellera Therapeutics Lda.
Acellera Therapeutics Lda. BiotechnologyHealth Technology Acellera Therapeutics Lda. engages in the development of platform technology for immunessupression to treat immune-mediated diseases. The company is headquartered in Lisbon, Portugal. | Health Technology |
Portugal Capital Ventures SCR SA
Portugal Capital Ventures SCR SA Investment ManagersFinance Portugal Capital Ventures SCR SA (Portugal Capital) is a venture capital firm founded in 1989. The firm is headquartered in Porto, Portugal. | Finance |
Lymphact - Lymphocyte Activation Technologies SA
Lymphact - Lymphocyte Activation Technologies SA BiotechnologyHealth Technology Lymphact - Lymphocyte Activation Technologies SA provides biotechnology solutions. It develops treatments for cancer and chronic viral diseases. The firm offers a technology platform that generates autologous and heterologous cellular immune therapies for clinical applications. The company was founded by Diogo Remechido in 2013 and is headquartered in Lisbon, Portugal. | Health Technology |
